Foster Victor Wealth Advisors’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4M Buy
394,595
+3,390
+0.9% +$184K 1.33% 15
2025
Q4
$18.9M Buy
391,205
+5,733
+1% +$267K 1.1% 25
2025
Q3
$16.7M Buy
385,472
+21,778
+6% +$851K 1.04% 38
2025
Q2
$14.2M Buy
363,694
+11,383
+3% +$435K 0.96% 45
2025
Q1
$12.2M Buy
352,311
+51
+0% +$1.87K 0.98% 48
2024
Q4
$11.8M Buy
352,260
+79,343
+29% +$2.86M 0.9% 52
2024
Q3
$11M Buy
272,917
+13,045
+5% +$534K 0.88% 51
2024
Q2
$10.1M Buy
259,872
+43,422
+20% +$1.83M 0.84% 51
2024
Q1
$8.83M Buy
216,450
+66,632
+44% +$2.75M 0.81% 60
2023
Q4
$5.94M Buy
149,818
+5,818
+4% +$209K 0.61% 61
2023
Q3
$5.28M Buy
144,000
+4,034
+3% +$143K 0.61% 62
2023
Q2
$4.86M Buy
139,966
+7,588
+6% +$272K 0.54% 64
2023
Q1
$4.84M Buy
132,378
+6,372
+5% +$223K 0.59% 60
2022
Q4
$4.4M Sell
126,006
-535
-0.4% -$17.8K 0.56% 63
2022
Q3
$3.8M Buy
126,541
+32,612
+35% +$1.24M 0.55% 63
2022
Q2
$5.06M Buy
93,929
+1,908
+2% +$105K 0.75% 56
2022
Q1
$5.26M Buy
92,021
+12,296
+15% +$668K 0.72% 56
2021
Q4
$4.51M Buy
79,725
+14,737
+23% +$767K 0.61% 61
2021
Q3
$3.1M Buy
64,988
+9,905
+18% +$498K 0.5% 62
2021
Q2
$2.74M Buy
55,083
+15,027
+38% +$722K 0.46% 70
2021
Q1
$1.8M Buy
40,056
+19,064
+91% +$865K 0.34% 80
2020
Q4
$966K Buy
20,992
+9,702
+86% +$446K 0.22% 84
2020
Q3
$531K Buy
11,290
+6,254
+124% +$313K 0.14% 92
2020
Q2
$257K Buy
+5,036
New +$258K 0.09% 103

Other funds holding GSK